Phobic disorders differ from generalized anxiety and panic disorders in that

Comorbidity of addictive problems: Assessment and treatment implications

Cecilia A. Essau, in Adolescent Addiction (Second Edition), 2020

11.2.2 Comorbidity between SUD and anxiety disorders

Anxiety disorders are among the most common psychiatric disorders in the general population, affecting up to 20% of adolescents. Anxiety disorders tend to be more common among females than males (Essau, Lewinsohn, Olaya, & Seeley, 2014). Adolescents meeting the criteria of anxiety disorders have been described as generally withdrawn, fearful of situations or objects, afraid of being in a social situation, and are inhibited (APA, 2013). In DSM-5, there have been some changes in the classification of anxiety disorders. Obsessive-compulsive disorder (included in the obsessive-compulsive and related disorders), acute stress disorder, and posttraumatic stress disorder (included in the trauma and stress-related disorders) are no longer considered anxiety disorders in DSM-5. Anxiety disorders which commonly occur in adolescents include social phobia (i.e., an irrational fear of being judged in social situations), specific phobia (i.e., a fear of specific objects or situations), generalized anxiety disorder (i.e., excessive and uncontrollable worry about life events), and panic disorder (i.e., discrete fear attacks that are associated with cognitive and physical symptoms).

Of all the anxiety disorders, social anxiety disorder is the one that most commonly co-occurs with AUD, with about 13% of those with social anxiety disorder having AUD (Buckner, Heimberg, Ecker, & Vinci, 2013; Schneier et al., 2010). It is estimated that 80% of the comorbid cases had social anxiety disorder before AUD; the presence of social anxiety disorder at baseline is associated with four times the odds of having AUD at follow-up (Schneier et al., 2010). Some authors consider drug consumption as a “means to an end” (Bulley, Miloyan, Brilot, Gullo, & Suddendorf, 2016, p. 64) such as managing a social situation. Indeed, one of the motivations to drink among individuals with social anxiety disorder is to provide relief or to reduce tension that arises in social situations and to facilitate social interactions. For example, a study by Battista, MacDonald, and Stewart (2012) showed that participants with social anxiety disorder spoke longer with an interaction partner after drinking alcohol; the interaction partner also showed more positive social behavior to participants with social anxiety disorder who drank alcohol compared to those who consumed a nonalcoholic beverage.

Most of the studies in comorbidity between SUD and anxiety disorders were conducted in Western countries. These findings, while informative, may not be generalizable to adolescents in non-Western countries. To make up this gap, Stapinski, Montgomery, and Araya (2016) conducted a study among adolescents in Chile to examine the extent to which depression, generalized anxiety, social anxiety, and panic symptoms independently predict new cases of cannabis use as well as to predict the frequency of use 18 months later. The findings showed a high comorbidity among the various types of substances such as between cannabis, tobacco, and alcohol use frequency. After adjusting for the use of cannabis at baseline, generalized anxiety, panic, and depressive symptoms were associated with a higher frequency of cannabis use 18 months later. However, after considering all predictors simultaneously, only generalized anxiety symptoms were independently associated with the frequency of subsequent cannabis use. Their finding also showed that among adolescents with high levels of generalized anxiety symptoms, the predicted probability of occasional and recurrent cannabis use was 39.8% and 5.9%, respectively. Among adolescents with low levels of generalized anxiety symptoms, the predicted probability of occasional and recurrent cannabis use was 21.1% and 1.6%, respectively. These findings were interpreted as supporting the internalizing pathway to substance use (Hussong, Jones, Stein, Baucom, & Boeding, 2011) in that adolescents with generalized anxiety, panic, and depression tend to use cannabis to cope with negative affects and tension and anxiety symptoms.

Read full chapter

URL: https://www.sciencedirect.com/science/article/pii/B9780128186268000116

Fear-Related Anxiety Disorders and Post-Traumatic Stress Disorder

Arshya Vahabzadeh, ... Kerry J. Ressler, in Neurobiology of Brain Disorders, 2015

Classification of Anxiety Disorders

The fourth edition of Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) and its text revision, DSM-IV-TR (which was current when this chapter was conceived), outlined 12 categories of anxiety disorder.3 In comparison to the earlier DSM-III, three new anxiety disorders were added to DSM-IV: acute stress disorder, anxiety disorder due to a general medical condition, and substance-induced anxiety disorder. The categorization of anxiety disorders was subsequently divided into anxiety, obsessive–compulsive, and trauma- and stressor-related disorders in the fifth edition, DSM-5, published in 2013 (Table 37.1).4 The historical aspects of anxiety disorder classification are of interest to clinicians and researchers since they underpin both research methodology and clinical treatment. In DSM-II, anxiety disorders were categorized under “neurosis”, a term which was later dropped from DSM-III. Three anxiety disorders were outlined in DSM-II, namely anxiety neurosis, phobic neurosis, and obsessive compulsive neurosis. DSM-III attempted to further subcategorize anxiety disorders, for example incorporating both generalized anxiety disorder and panic disorder. These diagnoses would have both fallen under anxiety neurosis in DSM-II; however, this new categorization reflected increasing knowledge about the disease course and treatment of these conditions. The increase in the number of categories seen in DSM-IV and DSM-5 could be perceived as an increasing recognition and awareness of the importance of anxiety disorders. However, some critics point out that the discriminative validity of these disorders may be undermined as we contend with increasingly significant overlap of symptomatology and comorbidity between anxiety and other psychiatric disorders.

TABLE 37.1. Categorization of Anxiety, Obsessive–Compulsive, and Trauma-Related Disorders in DSM-5

ANXIETY DISORDERS
Separation anxiety disorder
Selective mutism
Specific phobia
Social anxiety disorder (social phobia)
Panic disorder
Panic attack (specifier)
Agoraphobia
Generalized anxiety disorder
Substance/medication-induced anxiety disorder
Anxiety disorder due to another medical condition
Other specified anxiety disorder
Unspecified anxiety disorder
OBSESSIVE–COMPULSIVE AND RELATED DISORDERS
Obsessive–compulsive disorder
Body dysmorphic disorder
Hoarding disorder
Trichotillomania (hair-pulling disorder)
Excoriation (skin-picking) disorder
Substance/medication-induced obsessive–compulsive and related disorder
Obsessive–compulsive and related disorder due to another medical condition
Other specified obsessive–compulsive and related disorder
Unspecified obsessive–compulsive and related disorder
TRAUMA- AND STRESSOR-RELATED DISORDERS
Reactive attachment disorder
Disinhibited social engagement disorder
Post-traumatic stress disorder
Acute stress disorder
Adjustment disorders
Other specified trauma- and stressor-related disorder
Unspecified trauma- and stressor-related disorder

Source: American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th ed. DSM-5. Arlington, VA: American Psychiatric Publishing; 2013.4

A number of different anxiety disorders are described in DSM-5, including panic disorder, social phobia, PTSD, and generalized anxiety disorder. Several lines of research suggest that a majority of anxiety disorders may be conceptualized as disorders of fear.5,6 Large-scale population studies such as the NEMESIS study in the Netherlands have highlighted how a “fear” dimension appears to be integral to social phobia, specific phobia, agoraphobia, and panic disorder. Conversely, the NEMESIS study also found that although generalized anxiety disorder shares an “anxiety–misery” dimension similar to that of major depression and dysthymia, it does not share the “fear” dimension common to panic disorder, specific phobia, and PTSD.6 This reinforced previous findings by Krueger, who investigated patterns of psychiatric comorbidity using a sample of 8098 participants from the National Comorbidity Survey.5 Collectively, these findings are consistent with a subdivision of the broad class of anxiety disorders into disorders of anxiety and disorders of fear (Fig. 37.1).

Phobic disorders differ from generalized anxiety and panic disorders in that

FIGURE 37.1. Subcategorization of anxiety disorders based on symptoms.

Read full chapter

URL: https://www.sciencedirect.com/science/article/pii/B9780123982704000379

Behavioral Treatments for Anxiety in Minimally Verbal Children With ASD

Louis P. Hagopian, ... Thompson E. Davis, in Anxiety in Children and Adolescents with Autism Spectrum Disorder, 2017

Diagnosis

Anxiety disorders have been found to cooccur at highly variable rates, 11–84%, with ASD individuals (White et al., 2009). This variability may be due in part to the highly heterogeneous presentation of ASD as well as the complexity of the manifestations of anxiety in the ASD population, not to mention the biases which may be present for or against diagnosis in those with comorbid ASD. We continue to recommend use of the terms simple and anxious avoidance to help differentiate between stimuli and situations that may constitute an anxiety disorder in individuals with and without ASD. However, the current Diagnostic and Statistical Manual of Mental Disorders, 5th edition (DSM-5; American Psychiatric Association, 2013) classifies anxiety as the “anticipation of future threat” and furthermore, various anxiety disorders can be differentiated by the “specific content of the thoughts and beliefs that may induce the fear or anxiety.” Given this definition, how can the current diagnostic classifications of anxiety disorders be applied to those individuals with limited cognitive and/or verbal abilities? Early studies conducted on ASD suggested approximately half of those individuals diagnosed were incapable of speech acquisition (Rutter, 1978). Recent estimates have shown a marked decrease in these estimates due in part to earlier assessment and detection techniques (Klingler et al., 2003); however, the fact remains that some individuals with ASD never develop functional speech.

These deficits in verbal communication in a subpopulation of individuals with ASD may account for some of the variability in comorbidity rates. Researchers have shown higher levels of anxiety to be associated with functional language in individuals with ASD (Gadow and Sprafkin, 1998, 2002). Researchers have also argued these findings may be complicated by diagnostic overshadowing (Mason and Scior, 2004), while data from other studies suggests that individuals with ASD simply do not meet cooccurring criteria for other psychiatric conditions (Leyfer et al., 2006; Witmer and Lecavalier, 2010, Kaat et al., 2013). Differential diagnosis of ASD and anxiety, then, requires a careful evaluation of those symptoms unique to each disorder as well as common presentations of symptom patterns for individuals evincing comorbidity. Additionally, findings from a number of studies have shown that fears and behavioral responses common among the typically developing population, are not necessarily replicated in individuals with ASD (e.g., Evans et al., 2005; Kanner, 1943; Matson and Love, 1990).

Due to the overlap of symptomology between ASD and anxiety disorders a number of studies have attempted to differentiate those factors which are inextricably shared from those that may be conceptually differentiable. For example, social avoidance and a preference to be alone are shared qualities between both anxiety and ASD (Baron-Cohen et al., 2001; Roberson-Nay et al., 2007; White et al., 2012). However, ASD individuals may be less aware or have less concern for the social rejection component found in social anxiety disorder (Leyfer et al., 2006; Muris et al., 1998). Also, excessive worries around environmental changes or deviations from a schedule can be common in both groups of disorders (generalized anxiety disorder and ASD), as can be highly rigid behaviors, verbal rituals, and compulsions (OCD and ASD). The difficulty comes from determining whether these behaviors occur to reduce distress in the case of OCD or are generalized worry and broad anxious avoidance in the case of GAD. Differential diagnosis would also require the clinician to assess those behaviors seen less typically in non-ASD populations such as strict adherence to routine, circumscribed interests, and repetitive behaviors.

Attempts to distinguish between the similarities between anxiety and ASD symptoms have typically supported distinctiveness within areas which do not necessarily lend themselves to application in those who are minimally verbal or lower functioning. For example, Farrugia and Hudson (2006) found the only difference between anxiety presentation in typically developing and nontypically developing groups was reported thought patterns of social threat and physical injury, areas which would be difficult if not impossible to assess in a minimally verbal population. Atypical presentations of anxiety are also common in those with ASD and can include social fear without a negative evaluative component, nontraditional specific phobias, and fear of change and novelty (Kerns et al., 2014). Leyfer et al. (2006) found typical phobias were rarely endorsed in the ASD population; however, fears of loud noises, crowds, and shots/needles were much more common. Additionally, idiosyncratic fears (e.g., flushing toilets, beards, mechanical objects) have also been found in ASD individuals (Richman et al., 2012). Many of these problematic or avoided stimuli raise additional questions as to whether the problem is fear or anxiety versus altered sensory function. For example, repetitive and ritualistic behaviors seen in obsessive-compulsive disorder (OCD) are also commonly observed in many persons with ASD (McDougle et al., 1995), including those individuals that are not suspected of experiencing any anxiety. In such cases, repetitive behaviors may be a preferred self-stimulatory activity, in contrast to ritualistic behavior triggered by obsessional thoughts that is the hallmark of OCD. Caution should be taken to not immediately characterize these ritualistic or stereotypic behaviors as “OCD” based on their repetitive nature. Avoidance is another area which may present itself differentially as younger children and those with verbal deficits have been shown to express fear and avoidance in conjunction with other behaviors such as aggression, destruction of property, and self-injurious behavior (Hagopian et al., 2001; Ricciardi et al., 2006).

Finally, of particular concern with the diagnosis of anxiety in minimally verbal ASD populations is that strict adherence to the DSM-5 diagnostic criteria may miss a significant proportion of these individuals in need of clinical services due to verbal requirements of the diagnostic criteria. For example, Criterion A for separation anxiety disorder requires endorsement of 3 out of 8 symptoms; however, 4 of the 8 symptoms require the expression of “worry, thematic explanations of nightmares, or complaints” (APA, 2013). Additionally, some disorders such as selective mutism and GAD may inherently be unavailable to the minimally verbal ASD population when adhering to strict diagnostic classification. Given the host of challenges associated with differential diagnosis, thorough assessment procedures are considered to be vitally important.

Read full chapter

URL: https://www.sciencedirect.com/science/article/pii/B9780128051221000107

Linking Genes to Brain Function in Health and Disease

S.D. Norrholm, K.J. Ressler, in Neuroscience, 2009

Considerations for future genetic investigations of anxiety disorders: classification of environmental factors

An idea that was discussed above was the classification of anxiety disorders according to symptom dimensions as an alternative to diagnostic criteria. Kendler and others (2003) summarized findings of the Virginia Twin Registry and classified significant life events according to the nature of the event. Danger events were those that were related to an unpleasant adverse consequence. Humiliation events were those associated with rejection or failure. Loss events included occasions in which there was a real or perceived loss of a person, possession, or respect (Kendler et al., 2003). Given that the most effective genetic analyses of anxiety disorders will involve reliable G×E models, it is important to adequately define the nature of the life events that may interact with genetic risk factors to produce anxiety-related phenotypes.

Read full article

URL: https://www.sciencedirect.com/science/article/pii/S0306452209010616

Different patterns of freezing behavior organized in the periaqueductal gray of rats: Association with different types of anxiety

Marcus L. Brandão, ... Jesus Landeira-Fernandez, in Behavioural Brain Research, 2008

To make an integrative appraisal of the neural circuits proposed to underlie the different types of anxiety, we start with important changes that took place in the classification of anxiety disorders during the 1970s. During that time, most psychiatrists viewed anxiety as a single construct that ranged in intensity from normal to pathological or neurotic levels. Accordingly, anxiolytic drugs were the main prescription to treat this single disorder. A major shift to this view occurred in the beginning of 1980, with the publication of the 3rd edition of the American Psychiatric Classification (DSM-III) [1]. Some years later, the revised version of this classification established PD as an independent nosological category [2]. This new classification delineated distinct nosological entities, namely, GAD, PD, agoraphobia, simple phobias, social phobia, post-traumatic stress disorder, and obsessive–compulsive disorder. In general, the same proposal remained in the DSM-IV classification, being also adopted by the ICD-10 classification of the World Health Organization of 1992 [85].

Read full article

URL: https://www.sciencedirect.com/science/article/pii/S0166432807005633

Festschrift in Honour of Jeffrey Gray - Issue 1: Anxiety and Neuroticism

Frederico G Graeff, in Neuroscience & Biobehavioral Reviews, 2004

The final step was to correlate the above levels of predatory defense to anxiety-related emotions, normal as well as pathological. For this, it is necessary to take into account the developments that were taking place in the classification of anxiety disorders. A major shift in opinion occurred in 1980, when the 3rd Edition of the American Psychiatric Classification (DSM III) was released [3]. Replacing the preceding view that merged anxiety disorders in the undifferentiated pool of psychoneurosis, the DSM III classification delineated distinct nosological entities, namely PD, agoraphobia, simple phobias, social phobia, post-traumatic stress disorder, obsessive–compulsive disorder, and GAD. Except for a few changes in diagnostic criteria, the same theoretical stand remained in the revised version of DSM III [4] and in the DSM IV [5] classification, being also adopted by the ICD-10 classification of the World Health Organization [142]. Although these classifications are mainly based on overt symptoms and therapeutic response, it is implicit that different manifestations are likely to be due to distinct neural substrates. This motivated basic researchers in several fields to look for specific animal models and neural correlates for each disorder [143].

Read full article

URL: https://www.sciencedirect.com/science/article/pii/S0149763404000296

Twin studies of the covariation of pain with depression and anxiety: A systematic review and re-evaluation of critical needs

Waqas Ullah Khan, ... Marco Battaglia, in Neuroscience & Biobehavioral Reviews, 2020

2 Methods

This systematic review was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines (Moher et al., 2009). Institutional review board approval was waived as no patient data were accessed for the study.

2.1 Data sources and searches

We searched the Cochrane Database of Systematic Reviews, EMBASE (via OVID), MEDLINE (via OVID), and PsychInfo (via OVID) for studies published from inception through May 16, 2019. The literature search was conducted by the investigators after consulting with a librarian regarding the search strategy. The search strategy included terms for twin studies (twin, twin study, twin studies, or twin pair) combined with search terms for pain (pain, fibromyalgia, headache, migraine, angina, neuralgia, zoster, irritable bowel, ulcer, osteoarthritis, arthritis, temporomandibular joint, or musculoskeletal), depression (depression, depressed, depressive disorder, major depression, major depressive disorder, or MDD), and anxiety disorders (e.g., anxiety, panic disorder, agoraphobia, social phobia, social anxiety, generalized anxiety disorder, specific phobia, post-traumatic stress disorder, or obsessive compulsive disorder). Although neither PTSD nor OCD are part of the DSM-5 current classification of anxiety disorders, we included them in this review under anxiety disorders as the searched literature covered an extended period.

2.2 Study selection

Studies were included if they: (1) reported original data on twin studies; (2) reported on pain and depression and/or anxiety in twins; (3) were published in peer-reviewed journals; (4) used a validated method (including questionnaires) to assess for pain, anxiety, and depression; (5) had a sample size ≥100 twin pairs. If more than 1 study was conducted using the same dataset (i.e. same sample and same measures), they were included only if different research questions were tested. When there was an overlap in study samples, this was flagged in the results section to highlight the non-independence of findings. Studies that did not provide heritability estimates, quantitative genetic or environmental factor estimates, or did not use the classical twin or co-twin control method were excluded. Studies reporting concordance rates without a formal estimation of heritability were also excluded. Electronic searches were supplemented by examining the bibliographies of review articles to identify additional articles. Two authors (W.U.K. and M.B.) independently reviewed the titles, abstracts, and articles. A third author (G.M.) resolved discrepancies by discussion and adjudication.

2.3 Data extraction

Two authors (W.U.K. and M.B.) independently extracted the following information from eligible articles using a standardized form: first author’s name, year of publication, sample/registry name and country setting, study design, sample size, the number of twin pairs included in the study, the percentage of females in the sample, age of participants (mean and SD), the specific type of pain, anxiety, and depression assessed, the diagnostic instrument or rating scale used to measure pain, anxiety, and depression, and key findings from the study. One reviewer (W.U.K.) conducted a full abstraction of all data, and two reviewers (M.B. and G.M.) verified accuracy.

Read full article

URL: https://www.sciencedirect.com/science/article/pii/S0149763419306591

The effectiveness of eye movement desensitization and reprocessing toward anxiety disorder: A meta-analysis of randomized controlled trials

Ninik Yunitri, ... Kuei-Ru Chou, in Journal of Psychiatric Research, 2020

2 Methods

2.1 Identification and selection of studies

This study followed the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) guidelines. A comprehensive literature search of all articles published from the beginning of the databases up to December 2018 through CINAHL, Cochrane, Embase, Ovid, Scopus, PubMed, and Google Scholar databases. The search used medical subject headings (MeSHS) terms including: “eye movement desensitization and reprocessing” or “EMDR,” “anxiety disorders,” and “generalized anxiety disorder” or “GAD” or “phobia” or “panic disorder” and set a filter for RCT studies only.

The eligibility criteria for the current meta-analysis were studies that had a RCT design and tested the effectiveness of EMDR on anxiety disorders. This search was conducted according to the PICO (Population, Intervention, Comparison, and Outcomes) tool endorsed by the Cochrane Collaboration (Higgins and Green, 2008). We included all populations with anxiety disorders who received EMDR as a treatment therapy. The diagnosis could be made either clinically, based on diagnostic criteria, or with a score above the cut-off point on a self-report measure. According to the Diagnostic and Statistical Manual of Mental Disorders (DSM-5), the classification of anxiety disorders has changed drastically compared with the previous version. Currently, anxiety disorders include generalized anxiety disorder, social anxiety disorder, selective mutism, panic disorder, agoraphobia, and specific phobias. Studies with mixed diagnoses participants were included as long as anxiety disorder was the primary diagnosis. For the type of intervention, studies were included if they reported EMDR as the psychotherapy either in individual or group format. For comparison, any therapies including Therapy as Usual (TAU), waiting list-control, or another control psychological treatment were included in the study. In case a study was compared between two or more types of control groups, the effect size of EMDR was calculated against the passive control such as the waiting list or TAU. For outcomes, studies were included if they measured at least one of the following symptoms: anxiety, phobia, panic, behavioral/somatic and traumatic feelings. Only studies that were parallel randomized controlled trials were included. We excluded studies in which EMDR was combined with other forms of therapy or pharmacological interventions and studies that did not provide sufficient statistics for effect size calculations. Studies were not limited based on specific participant age or language. While searching for prospective studies, we supplemented the results by hand searching of meta-analyses and review articles.

2.2 Data extraction and risk of bias

The information extracted from the articles was organized by participant characteristics (sample size, age, and gender), diagnosis characteristics (criteria to diagnose and diagnosis), intervention characteristics (experiment and control group interventions’ type, the amount of sessions, duration of each session, frequency in a week, and total time of therapy), and outcomes (outcome indicators and assessment tools). One investigator extracted data and results were confirmed by another investigator before they were transferred and analyzed with a Comprehensive Meta-Analysis program (Version 3.0; Biostat Inc).

All included articles underwent a risk of bias (RoB) assessment using the Cochrane Handbook for Systematic Reviews of Interventions Version 2.0 to assess the quality. Two independent researchers assessed the RoB independently. There were five domains with potential risks of bias as follows: randomization process, deviation from intended intervention, missing outcome data, measurement of the outcome, and selection of the reported results. The assessment of bias was performed to conclude either the article had a low risk, some concern, or a high risk of bias. If disagreement occurred, a third party was included until consensus was reached through discussion. The Cohen's k for inter-rater reliability for the research quality assessment was 0.88.

2.3 Outcome measures

We analyzed outcome data on symptoms of anxiety, phobia, panic, behavioral/somatic and traumatic feelings. Some studies used more than one instrument to measure the same symptom. In terms of that situation, we selected the most frequently used measures across studies. As the primary outcome, the symptoms of anxiety were measured using; Test Anxiety Inventory (TAI) (Bauman and Melnyk, 1994; Cook-Vienot and Taylor, 2012; Gosselin and Matthews, 1995); Dental Anxiety Scale (DAS) (Doering et al., 2013); Beck Anxiety Inventory (BAI) (Feske and Goldstein, 1997; Goldstein et al., 2000; Zeighami et al., 2018); The Personal Report of Communication Anxiety-24 (PRCA-24) (Foley and Spates, 1995); Body Sensations Questionnaire (BSQ1) (Horst et al., 2017); Visual Analog Scale (VAS) (Littel et al., 2017); Anxiety and Depression Scale-Reduce (AD-R) (Passoni et al., 2018); State-Trait Anxiety Inventory (STAI) (Rathschlag and Memmert, 2014); State Anxiety-Behavioural Avoidance Test (SA-BAT) (Muris et al., 1998); and Hospital Anxiety Depression Scale (HADS) (Rahimi et al., 2018). Symptoms of phobia, panic disorder, somatic, and traumatic feelings were secondary outcomes. The symptoms of phobia were assessed using: Dental Fear Survey (DFS) (Doering et al., 2013); Agoraphobic Cognitions Questionnaire (ACQ) (Feske and Goldstein, 1997; Goldstein et al., 2000; Horst et al., 2017); Spider Phobia Questionnaire (SPQ) (Muris et al., 1997); Spider Phobia Questionnaire for Children (SPQ-C) (Muris et al., 1998); Agoraphobia Questionnaire (APQ) (Cook-Vienot and Taylor, 2012); and Imagery Fearsomeness rating (IFR) (Bates et al., 1996). Behavioral/somatic symptoms were measured by using: Brief Symptoms Inventory (BSI) (Doering et al., 2013; Feske and Goldstein, 1997); The Brief Body Sensations Interpretation Questionnaire (BBSIQ) (Goldstein et al., 2000); Body Sensations Questionnaire (BSQ) (Horst et al., 2017); and Behavioural Avoidance Test (BAT) (Muris and Merckelbach, 1997; Muris et al., 1997, 1998). Panic Appraisal Inventory (PAI) (Feske and Goldstein, 1997; Goldstein et al., 2000) and Impact Event Scale revision (IES-R) (Doering et al., 2013; Passoni et al., 2018)were the only tools used to assess symptoms of panic disorders and traumatic feelings respectively.

2.4 Publication bias

Publication bias only applied to the primary outcome of anxiety. Egger's regression intercept (Egger et al., 1997) and Begg rank correlation were used for examining publication bias. Egger's linear regression utilizes a logarithmic scale to analyze the funnel plot's asymmetry. A high correlation in Begg's test would indicate that the funnel plot is asymmetric. An asymmetric shape of the funnel plot would indicate the presence of publication bias.

2.5 Statistical analysis

Effect sizes (Hedges' g) were calculated for the difference between the baseline and post-treatment effects for both the EMDR and the control group. We did not analyze the differences between baseline and follow-up data because only four out of 17 articles conducted repeated measurements. Comprehensive Meta-Analysis software program version 3.0 was used to determine the treatment effect along with the effect size using a random-effects model. This approach was the most suitable because the effect size may vary among studies, which could lead to heterogeneity (Ahn and Kang, 2018; Barili et al., 2018; Y. H. Lee, 2018). Hedges' g was considered as the reference to calculate the effect size. The value of Hedges’ g 0.2, 0.5, and 0.8 represent small, medium, and large effect sizes.

Heterogeneity of effect sizes was based on Cochrane's Q or Q statistics and I2 statistic and a p-value of < 0.05. The degree of heterogeneity was divided into three levels, 25%, 50%, and 75%, corresponding to low, moderate, and high estimates, respectively. Considering that Cochrane's Q has low statistical strength, a p-value of <0.05 indicated heterogeneity (Y. H. Lee, 2018).

In the presence of heterogeneity, further analyses were required to determine the variance and moderating variables. EMDR therapy characteristics (duration of therapy, number of therapy sessions, the total time of therapy, type of control group therapy), and patients' characteristics (age and gender) were potential variables that could influence the effect size. A mixed-effects model was used to determine the effect size, Q statistics, and p-value between categorical variables, and a two-sided p-values was used for continuous variables. A significant p-value of <0.05 indicated the potential effects as moderator variables.

Read full article

URL: https://www.sciencedirect.com/science/article/pii/S0022395619313160

What is the difference between a panic disorder and a phobia?

Panic Disorder and Specific Phobias People who have a phobia will experience panic and anxiety when thinking about or being exposed to their fear. Panic disorder sufferers, on the other hand, are not generally triggered by a specific fear. People with panic disorder experience panic attacks suddenly and unexpectedly.

What are the key differences between generalized anxiety disorder and agoraphobia?

Agoraphobia: Excessive worry or fear in a place where escape is difficult such as a closed space, a large crowd, a bridge, tunnels or heights. Generalized anxiety disorder: characterized by excessive worry over everyday occurrences that usually do not produce worry in the general population.

What is the relationship between phobias and anxiety disorders?

A phobia is a type of anxiety disorder that causes an individual to experience extreme, irrational fear about a situation, living creature, place, or object. When a person has a phobia, they will often shape their lives to avoid what they consider to be dangerous.